Laboratory Considerations for Clinical Trials
Science:Life Sciences
With fewer people covering more roles with less specialization and novel therapeutics with unique testing requirements, the needs of small biotech companies in clinical trials are different from larger sponsors.
In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Mona Henderson, Director of Laboratory Network Solutions (both at Q2 Solutions) discuss how our dedicated biotech teams focus specifically on the unique needs of those customers.
Alex and Mona cover:
- Operational strategy, from supply chain to data management
- The role of LNS in contracting and managing specialty, third-party labs
- Collaboration with our parent company, IQVIA and
- Adapting to evolving customer strategies
You can learn more at https://q2labsolutions.com/biotech.
More Episodes
Risk Management for Biotech Companies in Clinical Trials
2022-05-16
172
2022-05-16
172
Managing Sample Data from Vendors
2021-09-14
214
2021-09-14
214
Automation within an ADME Laboratory
2021-08-26
197
2021-08-26
197
Bioanalytical Automation of Samples
2021-07-30
166
2021-07-30
166
Consent Tracking for Clinical Samples
2021-07-28
163
2021-07-28
163
Tracking Clinical Trial Samples
2021-07-28
158
2021-07-28
158
Avoiding Canceled Tests in Pediatric Samples
2021-02-02
139
2021-02-02
139
Covid Vaccine Testing
2020-09-15
185
2020-09-15
185
Hybrid Assays for Protein Bioanalysis
2020-07-29
148
2020-07-29
148
High Throughput ADME Testing
2020-07-29
95
2020-07-29
95
Liquid Biopsy Collection in Clinical Development Programs
2020-07-29
114
2020-07-29
114
Companion Diagnostic Strategies for Commercial Success
2019-02-26
194
2019-02-26
194
Get this podcast on your
phone, FREE
